C. Hasling
-
- Bone health and osteoporosis research 11
- Nephrology top 5%
- Parathyroid Disorders and Treatments 2
- Chronic Kidney Disease and Diabetes 2
-
- Bone health and treatments 10
-
- Thermoregulation and physiological responses 3
-
- Bone Metabolism and Diseases 3
-
- Pregnancy-related medical research 2
-
- Climate Change and Health Impacts 2
C. Hasling
25 papers receiving 819 citations
Peers
Comparison fields: 5 of 90
- Orthopedics and Sports Medicine 406
- Nephrology 148
- Endocrinology, Diabetes and Metabolism 150
- Oncology 230
- Pathology and Forensic Medicine 109
Countries citing papers authored by C. Hasling
This map shows the geographic impact of C. Hasling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hasling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hasling more than expected).
Fields of papers citing papers by C. Hasling
This network shows the impact of papers produced by C. Hasling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hasling. The network helps show where C. Hasling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Hasling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 27 | |
| 2 | Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. | 2000 | 89 |
| 3 | 1994 | 18 | |
| 4 | 1994 | 25 | |
| 5 | 1993 | 35 | |
| 6 | 1992 | 68 | |
| 7 | 1992 | 49 | |
| 8 | 1991 | 54 | |
| 9 | 1991 | 15 | |
| 10 | 1991 | 51 | |
| 11 | 1991 | 30 | |
| 12 | 1989 | 155 | |
| 13 | [Serum parathyroid hormone (1-84) assessed by immunoradiometric methods can differentiate malignant hypercalcemia and primary hyperparathyroidism]. | 1988 | 1 |
| 14 | 1987 | 12 | |
| 15 | Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D. | 1987 | 24 |
| 16 | 1987 | 38 | |
| 17 | 1987 | 27 | |
| 18 | [Treatment with sodium fluoride, calcium phosphate and vitamin D2 in spinal osteoporosis. Effect on calcium balance, calcium metabolism, bone remodelling, and side effects]. | 1986 | 1 |
| 19 | 1985 | 35 | |
| 20 | 1984 | 43 |
About C. Hasling
C. Hasling is a scholar working on Orthopedics and Sports Medicine, Nephrology and Developmental Biology, having authored 25 papers that have together received 868 indexed citations. Recurring topics across this work include Bone health and osteoporosis research (11 papers), Bone health and treatments (10 papers), Thermoregulation and physiological responses (3 papers), Bone Metabolism and Diseases (3 papers), Pregnancy-related medical research (2 papers), Climate Change and Health Impacts (2 papers), Parathyroid Disorders and Treatments (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (406 citations), Nephrology (148 citations) and Endocrinology, Diabetes and Metabolism (150 citations). C. Hasling has collaborated with scholars based in Denmark and Finland. Frequent co-authors include Leif Mosekilde, Peder Charles, Erik Fink Eriksen, Torben Steiniche, F. Melsen, H. Danielsen, Erland J. Erlandsen, Else Randers, Ole Lederballe Pedersen and L. Mosekilde. Their work appears in journals such as Bone, Calcified Tissue International, Journal of Bone and Mineral Research, European Journal of Clinical Investigation and Osteoporosis International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.